Patient: Page 28

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Kareem Saad -- Big Blue's Genomics Ace

    By Kim Ribbink Big Blue’s Genomics Ace Young and talented, Kareem Saad, IBM’s worldwide business segment executive for clinical genomics, is overseeing the company’s initiative to take clinical genomics from concept to market. With youthful enthusiasm, innate technical and scientific intelligence...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Talent Pool Executive Appointments and Promotions in the Healthcare Industry Pharma POOL Joy A. Amundson Bruce McGillivray Jim Utts Baxter Appoints and Promotes Executives Baxter International has named Joy A. Amundson corporate VP and president of its bioscience business. Baxter, Deerfield, Ill....

    By PharmaVoice Team • Jan. 2, 2008
  • drug shopping cart Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Commercialization, marketing and social media

    As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical. 

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Secret to Alliance Success

    Pharma Forum The Secret to Alliance Success By Denise Myshko Successful partnerships involve more than just signing a contract. Bringing drugs to market and then marketing those products more than ever hinges on how well alliances are managed from a strategic, operational, and organizational stan...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Risky Business

    Risky Business By Elisabeth Pena The pharmaceutical industry faces more inherent risks and higher stakes than almost any other industry because its products impact patient safety and well-being. Intensified public and media scrutiny about medication errors and drugs being pulled off the market ha...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Edward J. Ludwig -- A Global Citizen in a Changing World

    A Global Citizen in a Changing World By Kim Ribbink BD, a 100-plus-year-old medical-technology company, is blazing a global path with a purpose of helping all people live healthy lives thanks in large part to the progressive and determined efforts of its Chairman, Presid...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Era of Efficiency -- Provider Selection and the RFP Process

    Pharma Forum Era of Efficiency? Provider Selection and the RFP Process By Elisabeth Pena As procurement departments gain a stronger foothold within pharmaceutical companies, service providers are learning how to best work within the RFP process to create meaningful partnerships. Service providers...

    By PharmaVoice Team • Jan. 2, 2008